Hi NZT,
I have been following this stock for a while.
I have a question for you or others, if Fiona Wood said about SNT 6302 " not seen with any other form of treatment" , I can see SNT 9465 a true treatment for scarring due to its reformulation otherwise what is the point.
So how could SNT do a JV with the likes of J&J, Pfizer, AbbVie and Novartis ? Those Companies are into dermatology.
Secondly someone mentioned on this forum a while back that Syntara could spin SNT 6302 into a separate Company is that feasible?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $97.64M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| SNT (ASX) Chart |
Day chart unavailable